top of page


Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj DARATUMUMAB (DARZALEX) NIH National cancer institute - cancer.gov...
Patient Education
Dec 16, 2022


Patient Education: Lenalidomide - Immunomodulatory Agents - IMIDS
Patient Education: Revlimid (lenalidomide) - Immunomodulatory Agents - IMIDS LENALIDOMIDE (REVLIMID) NIH National cancer institute...
Patient Education
Dec 15, 2022


Patient Education: Bortezomib (Velcade) - Proteasome Inhibitor
Patient Education: Bortezomib (Velcade) - Proteasome Inhibitors BORTEZOMIB (VELCADE) NIH National cancer institute -cancer.gov site info...
Patient Education
Dec 10, 2022


Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor
Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor Carfilzomib NIH National cancer institute - cancer.gov site info This...
Patient Education
Dec 9, 2022


Patient Education: Ciltacabtagene Autoleucel - Carvykti - (CART Cell Therapy) - Immunotherapy
Patient Education: Ciltacabtagene Autoleucel https://www.carvykti.com Ciltacabtagene Autoleucel ( Carvykti) FDA approves ciltacabtagene...
Patient Education
Dec 6, 2022


Patient Education: Idecabtagene Vicleucel (CART Cell Therapy) - Immunotherapy
Patient Education: Idecabtagene Vicleucel ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically...
Patient Education
Dec 6, 2022


Patient Education: Isatuximab-irfc - Sarclisa - Monoclonal Antibody - Immunotherapy
Patient Education: Isatuximab-irfc - Sarclisa - Monoclonal Antibody - Immunotherapy ISATUXIMAB-IRFC (SARCLISA) NIH National cancer...
Patient Education
Dec 6, 2022


Patient Education: Pomalidomide (Pomalyst) Immunomodulatory Agents - IMIDS
Patient Education: Pomalidomide (Pomalyst) Immunomodulatory Agents - IMIDS POMALIDOMIDE (POMALYST) NIH National cancer institute -...
Patient Education
Dec 5, 2022


Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy
Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy ELOTUZUMAB (EMPLICITI) NIH National cancer...
Patient Education
Dec 4, 2022
bottom of page

